We are live on ! Find out more
EXAS

Exact Sciences

Delisted

EXAS was delisted on the 20th of March, 2026.

711 hedge funds and large institutions have $17.9B invested in Exact Sciences in 2025 Q4 according to their latest regulatory filings, with 254 funds opening new positions, 152 increasing their positions, 215 reducing their positions, and 98 closing their positions.

New
Increased
Maintained
Reduced
Closed

925% more funds holding in top 10

Funds holding in top 10: 441 (+37)

159% more first-time investments, than exits

New positions opened: 254 | Existing positions closed: 98

84% more capital invested

Capital invested by funds: $9.7B → $17.9B (+$8.18B)

75% more call options, than puts

Call options by funds: $359M | Put options by funds: $205M

25% more funds holding

Funds holding: 569711 (+142)

0.64% less ownership

Funds ownership: 93.65%93.01% (-0.64%)

29% less repeat investments, than reductions

Existing positions increased: 152 | Existing positions reduced: 215

Holders
711
Holders Change
+142
Holders Change %
+24.96%
% of All Funds
8.63%
Holding in Top 10
41
Holding in Top 10 Change
+37
Holding in Top 10 Change %
+925%
% of All Funds
0.5%
New
254
Increased
152
Reduced
215
Closed
98
Calls
$359M
Puts
$205M
Net Calls
+$154M
Net Calls Change
+$124M
Name Holding Trade Value Shares
Change
Change in
Stake
DT
326
Diversified Trust
Tennessee
$1.24M -$208K -2,591 -18%
SOAM
327
SBI Okasan Asset Management
Japan
$1.22M +$964K +12,000 New
CL
328
CSS LLC
Illinois
$1.21M +$959K +11,946 New
GRP
329
Global Retirement Partners
California
$1.2M +$269K +3,352 +40%
VT
330
Vise Technologies
New York
$1.19M +$937K +11,671 New
Walleye Capital
331
Walleye Capital
New York
$1.16M -$1M -12,499 -52%
PAS
332
Park Avenue Securities
New York
$1.16M -$602K -7,492 -40%
M&T Bank
333
M&T Bank
New York
$1.14M +$205K +2,549 +29%
OAM
334
Oppenheimer Asset Management
New York
$1.13M -$1.33M -16,591 -60%
SFA
335
Sequoia Financial Advisors
Ohio
$1.13M +$152K +1,895 +21%
RG
336
Rathbones Group
United Kingdom
$1.13M
Truist Financial
337
Truist Financial
North Carolina
$1.13M -$710K -8,837 -44%
Lido Advisors
338
Lido Advisors
California
$1.11M -$1M -12,475 -50%
X
339
Xponance
Pennsylvania
$1.1M +$48.3K +602 +6%
CP
340
CenterBook Partners
Connecticut
$1.08M +$854K +10,631 New
VCM
341
Voleon Capital Management
California
$1.07M +$452K +5,633 +115%
SCM
342
Sterling Capital Management
North Carolina
$1.07M -$31.3K -390 -4%
PNC Financial Services Group
343
PNC Financial Services Group
Pennsylvania
$1.05M -$50K -622 -6%
PRS
344
Pinkerton Retirement Specialists
Idaho
$1.04M +$824K +10,264 New
BCM
345
Brookstone Capital Management
Illinois
$1.04M +$11.9K +148 +1%
WCFA
346
Walkner Condon Financial Advisors
Wisconsin
$1.03M +$128K +1,588 +16%
AGM
347
Alpine Global Management
New York
$1.02M +$803K +10,000 New
COPPSERS
348
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.02M +$803K +10,000 New
OR
349
Olympiad Research
Connecticut
$1.01M +$795K +9,899 New
CT
350
Chicago Trust
Illinois
$989K

EXAS Hedge Fund Activity: Q4 2025 in Review

711 of the 8,238 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q4 2025, worth a combined $17.9B — up 84% from $9.7B a quarter earlier.

Buyers outnumbered sellers: 254 funds opened new EXAS positions and 98 closed out — a net gain of 156 holders — while 152 added to existing stakes and 215 trimmed.

The largest buyer was HBK Investments, opening a new position worth an estimated $614M. The largest seller was Fidelity Investments, cutting an estimated $1.41B.

  • 711 institutional investors held Exact Sciences (EXAS) as of Q4 2025, up from 569 in Q3 2025.
  • Funds reported $17.9B of Exact Sciences stock for Q4 2025, up 84% quarter-over-quarter.
  • 254 funds opened new Exact Sciences positions in Q4 2025 and 98 closed out, a net change of +156 holders.
  • The largest Exact Sciences buyer in Q4 2025 was HBK Investments, an estimated $614M added.
  • The largest Exact Sciences seller in Q4 2025 was Fidelity Investments, an estimated $1.41B sold.

Based on aggregated 13F filings for Q4 2025.